Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.5.3 to Revision: v3.5.4, representing a newer page version. This update pertains to metadata/formatting rather than substantive study details.
    Difference
    0.0%
    Check dated 2026-05-15T05:47:50.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s footer has been updated to indicate the ClinicalTrials.gov site revision was bumped from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:16:07.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added the Bologna location entries 'Province Of Bologna' and 'Bologna, Province Of Bologna, Italy, 15-40138' and removed the lowercase versions. Updated the revision tag to v3.5.2, replacing v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:44.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma tag added and a new resource entry for the Genetic and Rare Diseases Information Center. Page revision updated to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T05:29:30.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:26:14.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Added: Revision: v3.4.2. Removed: the funding-status notice and Revision: v3.4.1 banner. These changes do not affect the study details or the information presented on the page.
    Difference
    0.4%
    Check dated 2026-02-11T10:58:11.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.